|
Volumn 13, Issue 2, 2012, Pages 113-115
|
A new therapeutic strategy for malaria: Targeting T cell exhaustion
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABATACEPT;
ERYTHROCYTE MEMBRANE PROTEIN 1;
IMMUNOGLOBULIN G;
INTERLEUKIN 10;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
PROGRAMMED DEATH 1 LIGAND 1;
PROGRAMMED DEATH 1 LIGAND 2;
PROGRAMMED DEATH 1 RECEPTOR;
CANCER IMMUNOTHERAPY;
CD4+ T LYMPHOCYTE;
CELL FUNCTION;
DISEASE COURSE;
EXHAUSTION;
GENE EXPRESSION;
HEPATITIS B VIRUS;
HEPATITIS C VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
IMMUNE DEFICIENCY;
IMMUNE RESPONSE;
INFECTION;
MALARIA;
PLASMODIUM FALCIPARUM;
PLASMODIUM YOELII;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SHORT SURVEY;
T LYMPHOCYTE;
VIRUS INFECTION;
ANIMALS;
ANTIGENS, CD;
ANTIGENS, CD274;
CD4-POSITIVE T-LYMPHOCYTES;
FEMALE;
HUMANS;
MALARIA, FALCIPARUM;
PLASMODIUM FALCIPARUM;
|
EID: 84855940380
PISSN: 15292908
EISSN: 15292916
Source Type: Journal
DOI: 10.1038/ni.2211 Document Type: Short Survey |
Times cited : (26)
|
References (15)
|